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RUNNING TITLE: DETECTION OF HIV IN FEBRILE INDIVIDUALS 
ABSTRACT 
Introduction: The Human Immunodeficiency Virus (HIV) is the aetiological agent of Acquired Immunodeficiency 
Syndrome (AIDS), which is a chronic and potentially life-threatening condition. Fever is mostly associated with the early 
stage of virus replication known as acute HIV infection or syndrome; as such, determination of HIV status during this 
critical period is a good means of improving clinical outcome in those infected. Thus, this study aimed to determine the 
prevalence of HIV among febrile individuals in Lagos, Nigeria.  
Materials and Methods: A cross sectional study of 250 febrile individuals attending General Hospitals at Isolo, Mushin and 
Surulere, Lagos, Nigeria. Analysis was carried out at the Virology Research Laboratory, Central Research Laboratory, 
College of Medicine of the University of Lagos from July to October 2017. Sample analysis was done according to the 
Nigerian National Testing Algorithm to determine HIV status using Enzyme Immunoassay (EIA) and data analyzed using 
Statistical Package for Social Sciences (SPSS) version 20. 
Results: Out of the 250 febrile participants, 8 were positive for HIV, with an overall prevalence of 3.2%. Further analysis 
however showed that 90% of the HIV positive participants had four or more episodes of fever in a month. HIV infection 
was still majorly among the ages 15-24 and 25-34 for male and ages 25-34, 35-44 and 45-54 for females.  
Conclusion: This findings showed that different cohorts are significantly at risk of HIV infection. Hence, policies and all 
efforts to reduce the burden of HIV are paramount for a HIV free future for Nigeria. 
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TITRE : DÉTECTION DU VIH DANS LES INDIVIDUS FÉBRILES 
 
Résumé 
Introduction : Le virus de l'immunodéficience humaine (VIH) est l'agent causal du syndrome d'immunodéficience acquise 
(SIDA), qui est une maladie chronique et potentiellement mortel. La fièvre est le plus souvent associé avec le début de la 
réplication des virus connus sous le nom de l'infection à VIH aiguë ou un syndrome ; à ce titre, la détermination du statut 
VIH durant cette période critique est un bon moyen d'améliorer les résultats cliniques dans les personnes infectées. Ainsi, 
cette étude visait à déterminer la prévalence du VIH parmi les personnes fébriles à Lagos, Nigeria. 
Matériels et méthodes : Une étude transversale de 250 individus fébriles qui fréquentent les hôpitaux généraux à Dubuque, 
Mushin et Surulere, Lagos, Nigeria.                                                                                                                                                                                 
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L'analyse a été effectuée à la virologie, Laboratoire de recherche Laboratoire Central de recherche, Collège de médecine de 
l'Université de Lagos, de juillet à octobre 2017. L'analyse des échantillons a été faite selon le test national nigérian 
algorithme pour déterminer le statut sérologique à l'aide de dosage immunoenzymatique (EIA) et les données analysées en 
utilisant le progiciel de statistiques pour les sciences sociales (SPSS), version 20. 
Résultats : Sur les 250 participants fébriles, 8 étaient positifs pour le VIH, avec une prévalence globale de 3,2 %. Cependant 
d'autres analyses ont montré que 90  % des séropositifs les participants avaient quatre épisodes ou plus d'une fièvre dans 
un mois. L'infection à VIH est encore plus parmi les 15-24 ans et 25-34 ans pour les hommes et de l'âge 25-34, 35-44 et 45-54 
pour les femmes. 
Conclusion : Cette conclusions ont montré que différentes cohortes sont grandement à risque d'infection à VIH. Par 
conséquent, les politiques et tous les efforts visant à réduire le fardeau du VIH sont primordiales pour un avenir sans VIH 
pour le Nigeria. 
 
Mots-clés : syndrome rétroviral aigu (EI), de la fièvre, asymptomatiques et de dosage immuno-enzymatique (ELISA). 
 
INTRODUCTION 
The Human Immunodeficiency Virus (HIV) is a 
retrovirus known to cause human 
immunodeficiency infection, with sequel 
advancement to Acquired Immunodeficiency 
Syndrome (AIDS) if proper management is not 
instituted[1]. Since the initial recognition of AIDS 
as a distinct syndrome with associated severe and 
life-threatening clinical conditions, HIV/AIDS 
remains one of the world's most significant public 
health challenge[2],[3]. The pandemic proportion 
of HIV is further reflected in an estimated 36.7 
million people living with HIV-1 infection with 1.0 
million deaths from HIV-related causes globally in 
2016[3]. Furthermore, current estimates 
demonstrate very heterogeneous spread of HIV-1, 
but with Sub-Saharan Africa more affected, as 70% 
of the global total of new HIV infections has been 
reported from the region.[4] An estimated 60% of 
new HIV infections in Western and Central Africa 
in 2015 occurred in Nigeria, which is designated to 
have the second largest HIV epidemic in the 
world. Although HIV prevalence among adults is 
remarkably low (3.1%) compared to other Sub-
Saharan African countries such as South Africa 
(19.2%) and Zambia (12.9%), the size of Nigeria's 
population means 3.5 million people were living 
with HIV in 2015[4]. The sustained pandemicity of 
HIV is due to the multi route of transmission of 
the virus, with its chronicity perpetuated by the 
gradual depletion of primary cells of the immune 
defence; which among others include monocytes, 
macrophages and dendritic cells[5]. The sequel 
undermined immune response from these cells 
play a significant role in HIV pathogenesis, as 
there is a direct killing and increased apoptosis of 
these infected cells, which progresses to a total 
decline of CD4+ T cells if there is no appropriate 
treatment intervention[6].  
During the first few weeks following HIV-1 
acquisition, many people develop an acute 
retroviral syndrome (ARS), which is a set of 
nonspecific symptoms and signs that includes 
fever, body pain, fatigue among other 
symptoms[7]. There is a steep rise in the HIV-1 
viral load during this period that coincides with a 
spurt of inflammatory cytokines which is elicited 
as a febrile response in the individual[8]. Febrile 
illness or fever is a term for elevated body 
temperature, which is due to the body's natural 
reaction to invasion by an infectious  pathogen. It 
is clinically established when an individual has a 
temperature ≥ 38 oC and is one of the leading 
causes of visit to the hospital[9]. In Nigeria, major 
agents of febrile illnesses include Plasmodium 
falciparum responsible for malaria, Salmonella typhi 
(typhoid fever) plus a number of parasitic and 
viral infections[10]. While a number of persons can 
be positive for HIV but remain asymptomatic, 
fever is a common feature in HIV infected adults 
and may be a presenting sign of acute HIV-1 
infection or indeed HIV infection at any stage[10]. 
The association of fever with ARS has been shown 
by studies reporting up to 75% of individuals 
experiencing an acute ‘malaria-like’ illness 
approximately 2 weeks after infection[11],[12]. 
Furthermore, Bebell et al. reported in 2010, that 1–
3% of adults who sought care for suspected malaria 
in Uganda actually had acute or early HIV 
infection[13]. Considering the surge in HIV-1 
replication and viral load in individuals with ARS, 
who are highly contagious and the fact that such 
persons may not be aware of their status. Coupled 
with the fact that their febrile illness is often 
thought to be caused by malaria and typhoid fever 
in Nigeria; HIV status determination among these 
cohorts is clinically important for referral for early 
treatment, which promotes good clinical outcome 
for persons positive to HIV. Early detection is also 
significant for deterring spread of the virus by 
identifying persons at risk of HIV spread. Hence, 
the objective of this study was to detect HIV 
infection among febrile individuals presenting to 
the hospital for treatment, so as to determine the 
prevalence of HIV among febrile individuals, while 
promptly referring positive persons to a HIV 
treatment centre.  
SUBJECTS AND METHODS 
Study Centre/Site: A cross sectional study of febrile 
individuals at selected General Hospitals in Lagos 
State, Nigeria. Laboratory analysis was carried out 
at the Virology Research Laboratory, Central 
Research Laboratory, College of Medicine of the 
University of Lagos.  
Study Population: Study participants were 250 
individuals ≥ 15years of age who sort health care 
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for febrile illness at  General Hospitals (Isolo, 
Mushin, and Surulere) in Lagos State. Study 
population was calculated by the minimum sample 
size (N), determined using the equation as 
described by Pourhoseingholi et al in 2013[14]: 
n=Z2P(1−P)/d2 n=Z2P(1−P)/d2  
Where n= sample size, Z=statistics for a level of 
95% confidence interval=1.96, d= precision 
(allowable error) =5%=0.05. P=prevalence rate 
(3.17%) as reported by NACA[15]. The population 
of Isolo, Mushin, and Surulere are reported as 
837,300, 841,100 and 669,400 persons 
respectively[16]. Meanwhile, a minimum of 48 
participants were calculated for the study, but was 
marked up to 250 for improved quality of data. 
 
Ethical Consideration: Ethical approval with 
reference number CMUL/HREC/06/17/188 was 
obtained from the Health Research Ethics 
Committee (HREC), College of the Medicine of the 
University of Lagos. Duly informed consent was 
obtained from the participants that met criteria for 
the study.  
 
Inclusion criteria: Febrile individuals who do not 
have previous history of chronic illness and do not 
know their HIV status as at the time of presentation 
at the hospitals. 
 
Exclusion criteria: Acutely ill febrile individuals, 
those who declined participation and individuals 
less than 15 years of age were excluded from the 
study.   
 
Data/ Sample Collection and Storage: Socio-
demographic data was obtained by Health Research 
Ethics Committee validated structured interviewer 
administered questionaires. Participants designated 
as febrile after seeing the Clinician proceeded to 
sample collection for laboratory testing. Three to 
five mililitres (ml) of whole blood samples was 
collected into an EDTA bottle labelled with unique 
code for confidentiality and transported in cold 
chain using triple level packaging system to the 
laboratory. Samples were spun in the centrifuge 
(Eppendorf, Germany) at 300 rpm for 10 minutes 
and plasma separated into labelled cryovials and 
stored at in a freezer at -20 0C until analysis.  
 
Sample Analysis using Enzyme Immunoassay 
(EIA): Analysis of all samples to determine HIV 
status were done according to the Nigerian 
National Testing Algorithm (serial testing)[17] and 
according to the manufacturer’s instructions (Alere 
Determine HIV-1/2: Catalog number 
7D2342/7D2343; Trinity Biotech Uni-Gold: Catalog 
number 1206502; SD-Bioline HIV 1/2 3.0: Catalogue 
number: 03FK10CE. The test kits were rapid test 
based on the principle of Enzyme Immunoassay 
(EIA)[17]. All kits were checked before use to 
ascertain that they were not expired or damaged 
and all procedures were carried out using universal 
safety precautions.  
Statistical Analysis: Analysis was done using 
Statistical Package for Social Sciences (SPSS) version 
20 to compute descriptive data and prevalences, 
which were recorded as simple percentages. 
Associations between non-parametric variables 
were tested using Fishers’s exact test. The level of 
significance was set at 0.05. 
 
RESULTS 
Two hundred and fifty (250) febrile individuals 
were recruited for this study. There were 80 (32%) 
males and 170 (68%) females, giving a male/female 
ratio of 1:2.1. The mean age of the participants was 
36.5 years, with a range of ≥15 - 84 years. The 
demographic features of the febrile individuals are 
as shown in table 1, with no significant associations 
found among the demographic variables collated 
from the participants. 
                                                                                                                             
Out of the two hundred and fifty (250) samples 
analysed, 8 samples were positive for HIV, with an 
overall prevalence of 3.2% in these febrile 
individuals. Off these, 5 (62.5%) and 3 (37.5%) were 
females and males respectively without any 
statistical significant difference (p = 0.32) as shown 




TABLE 1: SOCIO-DEMOGRAPHIC CHARACTERISTICS OF STUDY PARTICIPANTS 
 
TABLE 2: PREVALENCE OF HIV AMONG FEBRILE INDIVIDUALS  
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Further analysis however showed that 90% of the 
positive participants had four or more episodes of 
fever in a month and HIV positive participants fell 
into the 15 to 54 years age range. Distribution and 
comparison of HIV positivity among the three 
general hospitals in Isolo, Mushin and Surulere 
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used for this study showed no statistical significant 
difference. HIV-1 detection among the 8 positive 
individuals from the study sites (Isolo, Mushin and 
Surulere) taking into consideration the numbers of 
samples collected from the sites were 2.5%, 4.1% 
and 3.6% respectively (figure 1).  
 
 
FIGURE 1: THE PERCENTAGE DISTRIBUTION 




Febrile illness or fever is a common reason for 
presenting and seeking healthcare in low and 
middle-income countries. Among patients with 
febrile illness requiring admission, case fatality 
ratios are high, sometimes exceeding 20%[18]. The 
many etiologies of fever are difficult to distinguish 
clinically and laboratory services may be limited or 
absent in such settings. Consequently, presumptive 
treatment significantly affects the proper 
management of febrile illnesses and HIV positive 
persons[18],[19]. These positive febrile individuals 
may probably be at the acute HIV-1 infection stage, 
remain asymptomatic, highly contagious and 
account for a large number of new HIV-1 infections. 
Thus, diagnosis and prompt initiation of Anti-
retroviral drugs (ARTs) for these and other cases of 
HIV infection should be identified as a ‘top priority’ 
for HIV prevention, particularly in Nigeria. 
The prevalence of 3.2% of HIV-1 among febrile 
individuals in this study falls within the overall 
range prevalence of 3.17% in Nigeria[15]. This 
finding shows that the burden of HIV infection in 
Nigeria is still a cause for concern particularly 
among febrile individuals seeking healthcare at 
various hospitals. Our finding among these febrile 
participants was similar to the study by Bebell et 
al.[13] who reported a similar prevalence of HIV 
among adults who sought care for suspected 
malaria in Uganda. Likewise, and also in 2010, 
Serna-Bolea et al.[20] reported that 3.3% of patients 
who sought care for fever at a district hospital in 
Southern Mozambique had acute HIV infection. 
However, the prevalence detected from this study 
was lower than respective 4.1%, 9%, 4.88% and 
11.4% reported from Oyo,[21] six geopolitical 
zones,[22] Plateau,[23] and Ogun States in Nigeria.[24]  
 
Our study also shows that positive samples were 
detected in the three locations, which are densely 
populated and are representative of most areas in 
Lagos. Corresponding variations in the prevalence’s 
in several reports from different parts of the 
country is majorly attributed to the different 
population samples, geographic locations, testing 
platforms and other socio-economic factors related 
to the population and site studied.  
In this study, more females presented at the 
hospitals seeking healthcare for febrile illnesses and 
were found to be more infected than males. 
Although, the percentage of positivity among males 
and females was not statistically significant. This 
findings was similar to the study of Omoniyi et 
al.[22] who also reported a higher prevalence in 
females than in males. The larger area of exposure 
in females (vagina/ comapared to the penis) has 
been known to put females at greater risk of HIV 
infection.  
                                                                                                                                      
A high prevalence of HIV infection was more 
prominent in age group < 54 years, also similar to 
the study by Omoniyi et al.[22] who reported high 
HIV prevalence within same age range. This is 
clearly indicative of the association of HIV with a 
more sexually active age group in our society; 
although, all gender and age groups are still at risk 
of HIV infection. 
While febrile patients should be encouraged for 
HIV testing, a provider-initiated HIV-1 testing and 
counseling (PITC) programme should be instituted 
for all patients visiting health facilities. 
Unfortunately the uptake of PITC has been low in 
sub-Saharan Africa[25]. Frequently mentioned 
reasons for the low uptake documented in literature 
include patient burden, absence of test kits, 
patients’ perceived HIV-1-negative status following 
a previous HIV-1 test, added costs for patients 
accessing care at private facilities and weak health 
systems in general[26]. However, focusing PITC 
efforts on patients with signs of acute infection (e.g. 
fever, sexually transmitted diseases, and diarrhea) 
may greatly reduce the number of patients 
requiring testing, while still allowing the 
identification of a large number of patients with 
undiagnosed prevalent HIV-1. Early detection 
through screening at the point of presentation for 
patients with febrile illness should be advocated for 
as a policy towards management. This would be 
significant for improved clinical care and reduction 
in HIV transmission in our environment. 
 
CONCLUSION                                                                                                                   
The findings in this study shows that HIV was 
detected in individuals with febrile illnesses and 
was detected more in the sexually active age. It is 









identification and monitoring of  patients 
presenting in Nigerian clinics with febrile 
conditions and engage them in voluntary HIV 
counselling and testing. Thus, the government at all 
levelsl should further support HIV prevention 
programmes in population at risk, particularly as 
identified in this study. 
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